The Pulmonary Panel NGS (Next-Generation Sequencing) Genetic Test offered by DNA Labs UAE is a cutting-edge diagnostic tool designed to identify genetic mutations associated with various pulmonary conditions. By analyzing a comprehensive panel of genes known to be linked to lung diseases, this test provides valuable insights that can guide personalized treatment plans and management strategies for patients. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. With the potential to uncover genetic predispositions and inform clinical decisions, the Pulmonary Panel NGS Genetic Test represents a significant advancement in the field of pulmonary medicine, offering hope for improved outcomes for individuals with inherited lung disorders.
The Atypical Hemolytic Uremic Syndrome (aHUS) Panel NGS Genetic Test, available at DNA Labs UAE for a cost of 4400 AED, is a comprehensive diagnostic tool designed to identify genetic mutations associated with atypical Hemolytic Uremic Syndrome. aHUS is a rare, life-threatening condition characterized by the triad of hemolytic anemia, thrombocytopenia, and acute kidney failure. This condition is primarily caused by genetic abnormalities that lead to uncontrolled activation of the complement system, an essential part of the immune response.
The test employs Next-Generation Sequencing (NGS) technology, a cutting-edge approach that allows for the simultaneous sequencing of multiple genes to detect mutations with high accuracy. This is crucial for conditions like aHUS, where mutations in several different genes can be responsible for the disease. The panel typically includes genes such as CFH, CFI, CD46 (MCP), C3, and others known to be associated with the disease.
By identifying specific genetic mutations, the aHUS Panel NGS Genetic Test can help in confirming a diagnosis of atypical Hemolytic Uremic Syndrome, guiding treatment decisions, and determining the risk of disease recurrence or familial transmission. This information is invaluable for affected individuals and their families for the management of the condition and for making informed healthcare decisions.
Given the complexity and potential severity of aHUS, the availability of this test at DNA Labs UAE represents a significant advancement in the accessibility of personalized medicine and genetic diagnostics in the region.
The Nephrology Panel NGS (Next-Generation Sequencing) Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic variations and mutations associated with a wide range of kidney-related diseases and conditions. This advanced testing method allows for the detailed analysis of multiple genes simultaneously, providing insights into the genetic predispositions or causes of nephrological disorders. With a cost of 4400 AED, the test is aimed at facilitating early diagnosis, personalized treatment planning, and better management of kidney diseases, ultimately improving patient outcomes. DNA Labs UAE utilizes cutting-edge technology and expertise to ensure accurate and reliable results, making the Nephrology Panel NGS Genetic Test a valuable resource for patients and healthcare providers alike in the pursuit of targeted nephrology care.
The Congenital Adrenal Hyperplasia (CAH) Panel NGS Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with CAH, a group of inherited disorders affecting the adrenal glands. This next-generation sequencing (NGS) test analyzes multiple genes known to be involved in the condition, providing a detailed assessment of genetic variations that could lead to CAH. By pinpointing specific genetic mutations, the test facilitates early and accurate diagnosis, allowing for personalized treatment plans and management strategies to be developed. The test is priced at 4400 AED, reflecting the advanced technology and expertise required to perform this sophisticated genetic analysis. Through early detection and intervention, individuals with CAH can lead healthier lives, making this test a valuable resource for those at risk or exhibiting symptoms of the disorder.
The Pancreatitis Panel NGS (Next-Generation Sequencing) Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with pancreatitis. Pancreatitis is an inflammatory condition of the pancreas that can lead to a range of health complications, and understanding the genetic basis of the disease can be crucial for effective management and treatment. This test screens for a wide array of genes known to be linked with hereditary pancreatitis, utilizing the advanced technology of next-generation sequencing to provide accurate and detailed genetic insights.
At a cost of 4400 AED, the test is a valuable investment for individuals with a personal or family history of pancreatitis, offering them a deeper understanding of their genetic predisposition to the condition. By pinpointing specific genetic mutations, healthcare providers can tailor treatment plans to the individual's genetic makeup, potentially improving outcomes and reducing the risk of complications. The test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services and commitment to high-quality patient care.
The "Infertility Panel NGS Genetic Test" is a comprehensive genetic screening designed to identify genetic factors that may contribute to infertility in individuals or couples struggling to conceive. Utilizing Next-Generation Sequencing (NGS) technology, this panel examines a wide array of genes known to be associated with various infertility issues, including but not limited to, hormonal imbalances, sperm production anomalies, and conditions affecting the reproductive system.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a deep insight into the genetic underpinnings of infertility, enabling healthcare providers to tailor treatment strategies more effectively. By pinpointing specific genetic abnormalities, the test can guide decisions on fertility treatments, such as in vitro fertilization (IVF), and provide valuable information for genetic counseling.
The cost of the Infertility Panel NGS Genetic Test at DNA Labs UAE is 4400 AED. Given the intricate technology and the comprehensive analysis it provides, this test represents a significant step forward for couples seeking to understand the genetic factors affecting their fertility and exploring targeted interventions to achieve pregnancy.
The Blood Coagulation Panel NGS Genetic Test offered by DNA Labs UAE is a comprehensive genetic screening designed to identify mutations and genetic variants that may affect blood clotting processes. This test is particularly valuable for individuals with a personal or family history of blood clotting disorders, such as deep vein thrombosis, hemophilia, or thrombophilia, among others. By utilizing Next-Generation Sequencing (NGS) technology, this panel can accurately analyze multiple genes associated with coagulation pathways, providing insights into an individual's risk factors for developing coagulation disorders.
The cost of the Blood Coagulation Panel NGS Genetic Test is 4400 AED. This investment in health can be pivotal in guiding clinical decisions, including the management and treatment of coagulation disorders. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures high-quality, reliable results, allowing for personalized healthcare strategies based on one's genetic makeup. Whether for diagnostic, predictive, or preventive purposes, this genetic test serves as a critical tool in understanding and managing blood coagulation-related health issues.
The Genodermatoses Exome Sequencing Panel Test is a sophisticated genetic test designed to diagnose various inherited skin disorders known collectively as genodermatoses. This cutting-edge test examines the exome, which represents all the genes in the genome that encode proteins, to identify mutations that may lead to skin diseases. By focusing on the exonic regions of the genome, where most disease-causing mutations are found, this panel offers a comprehensive approach to understanding the genetic underpinnings of complex skin conditions.
Offered at DNA Labs UAE, a leading facility in genetic diagnostics, the test is priced at 4400 AED. The test aims to provide actionable insights for patients and healthcare providers, enabling a more personalized approach to treatment and management of genodermatoses. It is especially valuable for individuals with a family history of skin disorders or those exhibiting symptoms without a clear diagnosis. With its precise focus on skin-related genetic disorders, the Genodermatoses Exome Sequencing Panel Test represents a significant advancement in dermatological genetics and personalized medicine.
The "Next Generation Sequencing (NGS) Maturity Onset Diabetes of Young (MODY) Test" is a cutting-edge diagnostic procedure offered by DNA Labs UAE, designed to identify genetic mutations associated with MODY. This condition, a form of diabetes, typically manifests before the age of 25 and is characterized by a strong family history of diabetes, differing from the more common types 1 and 2 diabetes in its genetic origins and treatment strategies. Utilizing the advanced NGS technology, the test examines multiple genes simultaneously, ensuring a comprehensive analysis and a high degree of accuracy in identifying the specific genetic variations responsible for MODY.
Priced at 5500 AED, the test represents a significant advancement in the personalized diagnosis and management of diabetes, enabling targeted treatment plans and better outcomes for affected individuals. By pinpointing the exact genetic mutation, healthcare providers can tailor interventions more precisely, potentially improving the quality of life for those with MODY. DNA Labs UAE, by offering this sophisticated diagnostic tool, underscores its commitment to leveraging cutting-edge genomic technologies to enhance patient care.
The "Nx Gen Sequencing Tuberous Sclerosis Complex Test" is an advanced genetic test available at DNA Labs UAE, specifically designed to diagnose Tuberous Sclerosis Complex (TSC), a genetic disorder characterized by the growth of noncancerous (benign) tumors in many parts of the body. Priced at 4400 AED, this test utilizes Next Generation Sequencing (NGS) technology to accurately identify mutations in the TSC1 and TSC2 genes, which are known to cause the condition. By examining the patient's DNA, this test can confirm a diagnosis of TSC, helping in the early detection and management of the disease. The NGS technology ensures a high level of sensitivity and specificity, making it a valuable tool for healthcare providers and patients in managing Tuberous Sclerosis Complex.
